Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly
2024年9月24日 - 2:01AM
Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology
company that develops plant traits to license to seed companies for
royalties, today announced that Peter Beetham, Co-Founder,
President and Chief Operating Officer, will participate in a panel
discussion titled “Sowing Solutions: Innovations in
Climate-Resilient Seeds” at the Food+ Forum during the 79th session
of the United Nations General Assembly (“UNGA”) in New York, NY, on
Thursday, September 26, at 12:50 pm ET.
“As a leader in the gene editing industry, Cibus
is enabling the agriculture industry’s efforts to address the
ramifications of climate change for the benefit of our global food
systems,” said Peter Beetham, Co-Founder, President, and Chief
Operating Officer at Cibus. “Our participation in the Food+ Forum
at the UNGA underscores the important role of gene editing
technology as a solution that can accelerate development timelines,
while also reducing cost, to ensure novel innovations find their
way to market as fast as possible. Cibus’
RTDS-based high throughput
breeding system is at the forefront of developing improved crops
that are more adaptive to changing environmental conditions,
helping to manage plant diseases and optimize nutrient usage. By
fostering global regulatory alignment, we can fully harness the
potential of gene editing to produce food that meets the needs of a
growing global population while bolstering farmer productivity in a
sustainable way.”
The Food+ Forum, hosted by Foreign Policy
Magazine, will convene leading experts, scientists, policymakers,
investors, and entrepreneurs who are building more sustainable food
systems, through advancing crop science and regenerative
agriculture, enhancing soil sustainability and nutrient density,
and providing innovative financing and safety nets to bolster food
system resilience. For more information or to register, please
visit: Food+ @ UNGA79 – Foreign Policy.
About Cibus
Cibus is a leading independent plant trait
company that develops and licenses plant traits to seed companies
for royalties. Cibus is not a seed company, but rather a technology
company that uses its proprietary gene editing technology to
develop and commercialize plant traits at a fraction of the time
and cost of conventional breeding. Cibus’ strategy is focused on
commercializing productivity traits for the world’s major row crops
with large acreage such as: canola, rice, soybean, corn and wheat.
The Company targets traits that help manage farmers’ seed
productivity and sustainability challenges such as weeds, disease,
and insects. The United Nations estimates that the impacts from
these challenges cost the global economy approximately $300 billion
annually. Cibus has a current portfolio of six traits, three of
which are in commercial development and four of which are
multi-crop traits associated with weed management and disease,
including Sclerotinia resistance and a new weed management trait
which are in advanced greenhouse and field trial stages.
About the Cibus Trait
Machine™ process and Rapid Trait Development
System™
A key element of Cibus' technology breakthrough
is its high-throughput breeding process (referred to as the Trait
Machine™ process). The Trait Machine process is a crop specific
application of Cibus' patented Rapid Trait Development System™
(RTDS®). The proprietary
technologies in RTDS integrate crop specific cell
biology platforms with a series of gene editing technologies to
enable a system of end-to-end crop specific precision breeding. It
is the core technology platform for Cibus' Trait Machine process:
the first standardized end-to-end semi-automated crop specific gene
editing system that directly edits a seed company's elite
germplasm. Each Trait Machine process requires a crop specific cell
biology platform that enables Cibus to edit a single cell from a
customer's elite germplasm and grow that edited cell into a plant
with the Cibus edits. Cibus has a Trait Machine process developed
for canola and rice and has already begun transferring their elite
germplasm with Cibus edits back to customers.
The traits from Cibus'
RTDS-based high-throughput breeding system are
indistinguishable from traits developed using conventional breeding
or from nature. RTDS does not integrate any
foreign DNA or transgenes. Under the European Commission's current
proposals, it is expected that products from Cibus'
RTDS gene editing platform such as its Pod Shatter
Reduction trait and Sclerotinia resistance traits for Canola and
Winter Oilseed Rape would be considered 'Conventional-like'.
Cibus believes that RTDS and
the Trait Machine process represent the technological breakthrough
in plant breeding that is the ultimate promise of plant gene
editing: "high-throughput gene editing systems operating as an
extension of seed company breeding programs." In 2024, the Trait
Machine process was cited by Fast Company Magazine as one of the
most innovative products in 2024.
Because the Trait Machine process is intended to
be integrated into seed companies' breeding operations, the
customer relationship between Cibus and seed companies with which
it engages is a collaborative relationship in which seed companies
transfer elite germplasm to have a specific validated trait placed
in the seed company's elite germplasm and expectation of delivery
back to the seed company of their elite germplasm with the Cibus
edit toward commercial development. Accordingly, Cibus refers to
seed company "customers" in its disclosure once such a customer
relationship has been initiated.
CIBUS CONTACTS:
INVESTOR RELATIONSKaren
Troeberktroeber@cibus.com858-450-2636
Jeff Sonnek – ICRjeff.sonnek@icrinc.com
MEDIA
RELATIONSmedia@cibus.com(619) 849-6009
Colin Sanfordcolin@bioscribe.com203-918-4347
Cibus (NASDAQ:CBUS)
過去 株価チャート
から 10 2024 まで 11 2024
Cibus (NASDAQ:CBUS)
過去 株価チャート
から 11 2023 まで 11 2024